1. Home
  2. MGTX vs UVV Comparison

MGTX vs UVV Comparison

Compare MGTX & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

BUY

Current Price

$10.89

Market Cap

1.0B

Sector

Health Care

ML Signal

BUY

Logo Universal Corporation

UVV

Universal Corporation

BUY

Current Price

$42.40

Market Cap

1.1B

Sector

Industrials

ML Signal

BUY

Company Overview

Basic Information
Metric
MGTX
UVV
Founded
2015
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
MGTX
UVV
Price
$10.89
$42.40
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $27.75
N/A
AVG Volume (30 Days)
★ 932.9K
284.1K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
★ 7.88%
EPS Growth
★ 33.02
N/A
EPS
★ 1.30
N/A
Revenue
$81,391,000.00
★ $2,885,078,000.00
Revenue This Year
$314.19
N/A
Revenue Next Year
N/A
$4.17
P/E Ratio
$8.40
★ N/A
Revenue Growth
★ 144.57
N/A
52 Week Low
$6.62
$41.10
52 Week High
$15.35
$59.38

Technical Indicators

Market Signals
Indicator
MGTX
UVV
Relative Strength Index (RSI) 31.37 32.91
Support Level $8.84 N/A
Resistance Level $11.85 $54.11
Average True Range (ATR) 0.58 0.89
MACD -0.18 -0.03
Stochastic Oscillator 13.29 30.89

Price Performance

Historical Comparison
MGTX
UVV

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Tobacco Operations segment involves procuring and processing flue-cured, burley, dark air-cured, and oriental leaf tobacco for manufacturers of consumer tobacco products and performing related services. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, the Philippines, Germany, and Other Countries, with the majority of revenue from the USA.

Share on Social Networks: